2m 2m 2m 2m 2m 2m 2m
NRX PHARMA (NRXP)
NASDAQ
$4.06-$0.56 (-12.03%)
Price as of Jun 03, 2026 7:56 PM EDT- $160.1MMarket Cap
- 69.85%1-Year Change
- BiotechnologyIndustry
NRX PHARMA (NRXP)
$4.06-$0.56 (-12.03%)
NRXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.62 | ||
Change | $0.00 (0.00%) | ||
Open | $4.65 | ||
High | $5.05 | ||
Low | $4.58 | ||
Previous Close | $4.62 | ||
Volume | 2,173,387 | ||
30-Day Average Volume | 1,472,968 | ||
1-Week Change | 7.19% | ||
1-Month Change | 49.51% | ||
1-Year Change | 69.85% | ||
3-Year Change | -48.09% | ||
5-Year Change | -97.81% | ||
Fundamentals | |||
Shares Outstanding | 36.2M | ||
Total Assets | $11.9M | ||
Market Cap | $160.1M | ||
Enterprise Value | $153.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$4.3M | ||
EBIT | -$1.4M | ||
EBITDA | -$1.4M | ||
Net Working Capital | -$17.8M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -112 | ||
Enterprise Value/Revenue | 144 | ||
P/B | -12 | ||
P/E | -111 | ||
PEG | -2 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/02/2024 | ||
Earnings & Revenue